This paper presents three cases of recurrent urinary tract infections from urethral mesh erosion after transobturator midurethral sling (MUS) surgery. The patients were operated on using a MUS with a mesh for stress urinary incontinence. A few years after surgery (0.3 to 7 years), patients complained of recurrent pain in the urethra with voiding symptoms. In all cases, urethrocystoscopy was performed and an erosion of the sling directly across the urethra was found. Patients were managed by dissecting the urethra and removing the mesh via the transvaginal approach under general anesthesia.
INTRODUCTION
Midurethral slings (MUS) with a vaginal mesh are an effective treatment modality for SUI with high cure rates ranging from 64-97% at the 10-year follow-up [1] [2] [3] . Despite their efficacy in treating SUI, these meshes can be associated with a range of complications. Of these, 0.4-6.7% of patients developed mesh erosion in a large series [4] [5] [6] [7] . Of these complications, however, vaginal extrusion was the most common complication. Despite this, there are few reports and case series of mesh erosion into the urinary tract following sling placement published [8] [9] [10] . The precise pathophysiology associated with mesh erosion is not completely understood [11, 12] . This paper presents three cases of recurrent urinary tract infections from urethral mesh erosion after transobturator MUS surgery.
CASE REPORTS

Case 1
A 64-year-old female was operated on with a transobturator (TOT) surgery for stress urinary incontinence (SUI) in 2008. The patient was referred to this hospital because of recurrent pain in the urethra and frequency from six months ago. Urethrocystoscopy was performed and an erosion of the sling directly across the urethra was found ( Fig. 1 ). The urine culture revealed the growth of extendedspectrum beta-lactamase-producing Escherichia coli ＞100,000 colony/ml. According to the antibiotic susceptibility, ertapenem 1 g/day was applied preoperatively. The patient was managed by dissecting the urethra and removing the mesh via the transvaginal approach under general anesthesia. Two weeks after surgery, the urethral catheter was removed after cystourethrography. After surgery, the patient showed improvements in the recurrent urinary tract infection and frequency symptoms. No bacteria were observed in the urine test. Six months after surgery, the patient complained of recurrent pain in the urethra. Urethrocystoscopy revealed a tiny mesh stripe at the 3 o'clock position in the urethra.
The second endoscopic management was performed using Holmium laser excision. After a three year follow-up, the mesh was not observed by urethrocystoscopy and the patient had no SUI symptoms.
Case 2
A 74-year-old female underwent a TOT for SUI. The patient's body mass index (BMI) was 24.2 and she was taking medication for type II diabetes. Seven years after surgery, the patient experienced urgency urinary incontinence (UUI) together with urethral pain. The patient was treated with antibiotics for urethritis, but the symptoms recurred frequently over a one-year period. She was referred to the authors' institution with those symptoms. An urethrocystoscopy revealed urethral mesh erosion. E.coli ＞100,000 colony/ml were isolated from the urine culture and sensitive antibiotics were given according to the urine culture. The patient was managed by dissecting the urethra and removing the mesh via the transvaginal approach under general anesthesia. A urethral catheter was applied for two weeks.
At the one year follow-up, the mesh was not observed by urethrocystoscopy, but the symptoms of SUI relapsed.
Surgery for SUI was recommended, but she did not want further operative treatment.
Case 3
A 64-year-old female underwent a mini-sling surgery for SUI. Her medical history revealed a BMI of 17.4 and that she had undergone a thyroidectomy and medication for hypercholesterolemia. The patient was referred to the authors' institution with recurrent pain in the urethra during voiding shortly after surgery. Urethrocystoscopy revealed an erosion of the mesh across the urethra. In the urine culture after surgery, Enterococcus faecalis ＞100,000 colony/ml were found and sensitive antibiotics were administered according to the urine culture. and its vascularity [11, 12, 14, 15] . Direct surgical injury to the urethra has been suspected as the cause of urethral mesh erosion [16] .
The rates of UTI vary widely according to the definition of UTI (symptom-based, treatment-based or cultural-based) or surgical procedure performed (transobturator approach or retropubic approach). Moreover, a low incidence of recurrent UTI has been reported in 0.3-6.4% of patients after MUS surgery compared to pelvic organ prolapsed surgery [4, 17, 18] .
Recurrent UTI due to mesh erosion to the urinary tract is not frequent but can be treated effectively by surgical correction. Therefore, it is important to diagnose mesh For urethral erosions, transvaginal urethroplasty was performed to remove the urethral mesh. A study reported the long-term results of transurethral endoscopic excision of the urethra using a Holmium laser [22] . In this study, six out of twelve patients were resolved using that procedure: two with multiple procedures. Six patients required a secondary transvaginal approach, including two small urethrovaginal fistulas. If a regular cystoscope is difficult to work with, a pediatric cystoscope can be used with a clamp and/or scissors alongside the scope to access the mesh to cut it. [23, 24] .
In this study, the time from surgery to the onset of symptoms was 0.3 to 7 years. For this reason, patients with a mesh should have a long-term (more than 10 years) follow-up to monitor for complications or a delayed onset of symptoms [25] .
In conclusion, although the precise pathophysiology of urethral mesh erosion is not completely understood, the current case underscores the importance of cystourethroscopy, particularly in situations where the patients present with recurrent symptoms of urinary tract in UTI after the
